Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction

• Verena Paulitschke,

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Silke Gruber,

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Elisabeth Hofstätter,

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Verena Haudek-Prinz,

  Affiliation Department of Medicine I, Medical University of Vienna, Vienna, Austria

  ⨯
• Philipp Klepeisz,

  Affiliation Department of Medicine I, Medical University of Vienna, Vienna, Austria

  ⨯
• Nikolaus Schicher,

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Constanze Jonak,

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Peter Petzelbauer,

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Hubert Pehamberger,

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Christopher Gerner,

  Affiliation Department of Medicine I, Medical University of Vienna, Vienna, Austria

  ⨯
• Rainer Kunstfeld

  * E-mail: rainer.kunstfeld@meduniwien.ac.at

  Affiliation Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯